| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |